| Thomas Bender, AA | |
|
40 W Erie St, Suite 203, Painesville, OH 44077-3274 | |
| (440) 350-0832 | |
| (440) 354-7420 |
| Full Name | Thomas Bender |
|---|---|
| Gender | Male |
| Speciality | Anesthesiology Assistant |
| Experience | 16 Years |
| Location | 40 W Erie St, Painesville, Ohio |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1003063728 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 367H00000X | Anesthesiologist Assistant | 852 (Ohio) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Wooster Community Hospital | Wooster, OH | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Ohio Anesthesia Group, Inc | 9537222138 | 166 |
News Archive
Anika Therapeutics, Inc. (Nasdaq: ANIK), a leader in products for tissue protection, healing and repair based on hyaluronic acid (HA) technology, today announced that it has received Health Canada approval for MONOVISC™, its single injection viscosupplement approved for the treatment of osteoarthritis of the knee. Anika expects to launch MONOVISC this month through its long-term ORTHOVISC® distribution partner in Canada, Rivex Pharma Inc., the specialty drug distribution division of Aurora, Ontario-based Helix BioPharma Corp. (TSX: HBP). MONOVISC has been broadly available in the European Union since the second quarter of 2008.
Children conceived via infertility treatments are no more likely to have a developmental delay than children conceived without such treatments, according to a study by researchers at the National Institutes of Health, the New York State Department of Health and other institutions.
In addition, diabetic women in the study who also had kidney disease or obesity, or whose diabetes was poorly controlled (fasting blood sugar levels above 300 mg/dL) had a risk of heart failure 6-10 times higher than that of women without diabetes.
Patients with mastocytosis show elevated bone turnover that is associated with a higher mast cell load and advanced disease relative to individuals without the condition, suggest study findings.
The results of an online questionnaire of 609 breast cancer survivors in the U.S. suggest that nearly half of patients experienced delays in care during the early weeks of the COVID-19 pandemic. The study, by researchers at the University of Illinois Chicago, is published in the journal Breast Cancer Research and Treatment.
› Verified 4 days ago
| Entity Name | Consultant Anesthesiologists Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1457420580 PECOS PAC ID: 3577467109 Enrollment ID: O20031125000053 |
News Archive
Anika Therapeutics, Inc. (Nasdaq: ANIK), a leader in products for tissue protection, healing and repair based on hyaluronic acid (HA) technology, today announced that it has received Health Canada approval for MONOVISC™, its single injection viscosupplement approved for the treatment of osteoarthritis of the knee. Anika expects to launch MONOVISC this month through its long-term ORTHOVISC® distribution partner in Canada, Rivex Pharma Inc., the specialty drug distribution division of Aurora, Ontario-based Helix BioPharma Corp. (TSX: HBP). MONOVISC has been broadly available in the European Union since the second quarter of 2008.
Children conceived via infertility treatments are no more likely to have a developmental delay than children conceived without such treatments, according to a study by researchers at the National Institutes of Health, the New York State Department of Health and other institutions.
In addition, diabetic women in the study who also had kidney disease or obesity, or whose diabetes was poorly controlled (fasting blood sugar levels above 300 mg/dL) had a risk of heart failure 6-10 times higher than that of women without diabetes.
Patients with mastocytosis show elevated bone turnover that is associated with a higher mast cell load and advanced disease relative to individuals without the condition, suggest study findings.
The results of an online questionnaire of 609 breast cancer survivors in the U.S. suggest that nearly half of patients experienced delays in care during the early weeks of the COVID-19 pandemic. The study, by researchers at the University of Illinois Chicago, is published in the journal Breast Cancer Research and Treatment.
› Verified 4 days ago
| Entity Name | Anesthesia Associates Of Wooster |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1750320693 PECOS PAC ID: 7618937822 Enrollment ID: O20041012001571 |
News Archive
Anika Therapeutics, Inc. (Nasdaq: ANIK), a leader in products for tissue protection, healing and repair based on hyaluronic acid (HA) technology, today announced that it has received Health Canada approval for MONOVISC™, its single injection viscosupplement approved for the treatment of osteoarthritis of the knee. Anika expects to launch MONOVISC this month through its long-term ORTHOVISC® distribution partner in Canada, Rivex Pharma Inc., the specialty drug distribution division of Aurora, Ontario-based Helix BioPharma Corp. (TSX: HBP). MONOVISC has been broadly available in the European Union since the second quarter of 2008.
Children conceived via infertility treatments are no more likely to have a developmental delay than children conceived without such treatments, according to a study by researchers at the National Institutes of Health, the New York State Department of Health and other institutions.
In addition, diabetic women in the study who also had kidney disease or obesity, or whose diabetes was poorly controlled (fasting blood sugar levels above 300 mg/dL) had a risk of heart failure 6-10 times higher than that of women without diabetes.
Patients with mastocytosis show elevated bone turnover that is associated with a higher mast cell load and advanced disease relative to individuals without the condition, suggest study findings.
The results of an online questionnaire of 609 breast cancer survivors in the U.S. suggest that nearly half of patients experienced delays in care during the early weeks of the COVID-19 pandemic. The study, by researchers at the University of Illinois Chicago, is published in the journal Breast Cancer Research and Treatment.
› Verified 4 days ago
| Entity Name | Ohio Anesthesia Group, Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1639348113 PECOS PAC ID: 9537222138 Enrollment ID: O20090108000069 |
News Archive
Anika Therapeutics, Inc. (Nasdaq: ANIK), a leader in products for tissue protection, healing and repair based on hyaluronic acid (HA) technology, today announced that it has received Health Canada approval for MONOVISC™, its single injection viscosupplement approved for the treatment of osteoarthritis of the knee. Anika expects to launch MONOVISC this month through its long-term ORTHOVISC® distribution partner in Canada, Rivex Pharma Inc., the specialty drug distribution division of Aurora, Ontario-based Helix BioPharma Corp. (TSX: HBP). MONOVISC has been broadly available in the European Union since the second quarter of 2008.
Children conceived via infertility treatments are no more likely to have a developmental delay than children conceived without such treatments, according to a study by researchers at the National Institutes of Health, the New York State Department of Health and other institutions.
In addition, diabetic women in the study who also had kidney disease or obesity, or whose diabetes was poorly controlled (fasting blood sugar levels above 300 mg/dL) had a risk of heart failure 6-10 times higher than that of women without diabetes.
Patients with mastocytosis show elevated bone turnover that is associated with a higher mast cell load and advanced disease relative to individuals without the condition, suggest study findings.
The results of an online questionnaire of 609 breast cancer survivors in the U.S. suggest that nearly half of patients experienced delays in care during the early weeks of the COVID-19 pandemic. The study, by researchers at the University of Illinois Chicago, is published in the journal Breast Cancer Research and Treatment.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Thomas Bender, AA 40 W Erie St, Suite 203, Painesville, OH 44077-3274 Ph: (440) 350-0832 | Thomas Bender, AA 40 W Erie St, Suite 203, Painesville, OH 44077-3274 Ph: (440) 350-0832 |
News Archive
Anika Therapeutics, Inc. (Nasdaq: ANIK), a leader in products for tissue protection, healing and repair based on hyaluronic acid (HA) technology, today announced that it has received Health Canada approval for MONOVISC™, its single injection viscosupplement approved for the treatment of osteoarthritis of the knee. Anika expects to launch MONOVISC this month through its long-term ORTHOVISC® distribution partner in Canada, Rivex Pharma Inc., the specialty drug distribution division of Aurora, Ontario-based Helix BioPharma Corp. (TSX: HBP). MONOVISC has been broadly available in the European Union since the second quarter of 2008.
Children conceived via infertility treatments are no more likely to have a developmental delay than children conceived without such treatments, according to a study by researchers at the National Institutes of Health, the New York State Department of Health and other institutions.
In addition, diabetic women in the study who also had kidney disease or obesity, or whose diabetes was poorly controlled (fasting blood sugar levels above 300 mg/dL) had a risk of heart failure 6-10 times higher than that of women without diabetes.
Patients with mastocytosis show elevated bone turnover that is associated with a higher mast cell load and advanced disease relative to individuals without the condition, suggest study findings.
The results of an online questionnaire of 609 breast cancer survivors in the U.S. suggest that nearly half of patients experienced delays in care during the early weeks of the COVID-19 pandemic. The study, by researchers at the University of Illinois Chicago, is published in the journal Breast Cancer Research and Treatment.
› Verified 4 days ago
Mr. Gregory J Rivenbark, CAA Anesthesiologist Assistant Medicare: Medicare Enrolled Practice Location: 7757 Auburn Rd Ste 15, Painesville, OH 44077 Phone: 440-350-0832 | |
Matthew Ciotti, AA Anesthesiologist Assistant Medicare: Accepting Medicare Assignments Practice Location: 40 W Erie St, Suite 203, Painesville, OH 44077 Phone: 440-350-0832 Fax: 440-354-7420 | |
Marcus Steven Bartels, AA Anesthesiologist Assistant Medicare: Medicare Enrolled Practice Location: 7590 Auburn Rd, Painesville, OH 44077 Phone: 440-350-0832 Fax: 440-579-0191 |